// App-Quantinova.ai

: The Difference Between eGFR by Cystatin C vs. Creatinine Provides Clinical Information About Frailty in CHS

Researchers

Presenter

  • O. AlisonPotok

Principal Investigators

  • RonitKatz

  • NishaBansal

  • DavidSiscovick

  • JoachimH.Ix

  • MichaelShlipak

  • DenaE.Rifkin

Medical Centers

  • Alison, UCSD, San Diego, California, United States

  • University of Washington, Seattle, WA, United States

  • Kidney Research Institute, Seattle, Washington, United States

  • UC San Diego, San Diego, California, United States

  • San Francisco Veterans Affairs Medical Center, San Francisco, California, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Creatinine

  • Cystatin C

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A